Description
An activator of Wnt/β-catenin signaling; increases β-catenin responsive transcription in a cell-based reporter assay in a concentration-dependent manner; increases β-catenin protein levels in HEK293 cells at 10 and 30 μM; disrupts the interaction between Axin and β-catenin; increases ALP activity and mineralization in multipotent mesenchymal ST2 cells, indicating increased osteoblastogenesis; reduces HCT116 and HT-29 spheroid growth and inhibits proliferation of HCT116 and HT-29 cells at 40 μM; induces cell cycle arrest at G0/G1 phase and increases E-cadherin and β-catenin protein levels in HCT116 cells at 40 μM
Formal name: 5-(2-furanyl)-N-[3-(1H-imidazol-1-yl)propyl]-3-isoxazolecarboxamide
Synonyms: Wnt Agonist II
Molecular weight: 286.3
CAS: 909089-13-0
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Cancer|Cell Cycle|G1||Research Area|Cancer|Cell Signaling|Wnt Signaling||Research Area|Cell Biology|Cell Signaling|Wnt Signaling||Research Area|Endocrinology & Metabolism|Bone Growth & Remodeling